Future Medicine Co., Ltd. (XKON:341170)
South Korea
· Delayed Price · Currency is KRW
1,598.00
-85.00 (-5.05%)
At close: Mar 9, 2026
Future Medicine Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2021 | FY 2020 | FY 2019 |
| Mar '26 Mar 6, 2026 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Debt / Equity Ratio | 0.04 | 0.04 | -0.61 | -0.91 |
| Net Debt / Equity Ratio | -0.79 | -0.84 | -0.11 | -0.59 |
| Net Debt / EBITDA Ratio | 0.78 | 0.96 | -0.29 | -0.86 |
| Net Debt / FCF Ratio | 0.72 | 0.90 | -0.38 | -0.84 |
| Asset Turnover | - | 0.12 | - | - |
| Quick Ratio | 9.08 | 10.78 | 0.35 | 0.56 |
| Current Ratio | 9.62 | 11.38 | 0.35 | 0.58 |
| Return on Assets (ROA) | - | -47.87% | -52.88% | - |
| Return on Capital Employed (ROCE) | -100.40% | -86.20% | 47.20% | 888.20% |
| Buyback Yield / Dilution | - | -16.65% | -6.69% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.